JPRN-UMIN000017842已完成未知
Investigation of correlation between pharmacokinetics of midazolam and DNA methylation in hepatic derived cells to predict CYP3A4 activity - Investigation of correlation between pharmacokinetics of midazolam and DNA methylation
Clinical Pharmacokinetics, Graduate School of Pharmaceutical Sciences, Kyushu University0 个研究点目标入组 20 人开始时间: 2015年6月12日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 45years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •The investigators must ensure that all subjects being considered meet the following exclusion criteria or conditions: 1) history of allergy to any drugs 2) medical attention within 2 months prior to participation 3) donation of 200 mL or more of blood within 4 weeks prior to participation, or donation of component blood within 2 weeks prior to participation 4) donation of 400 mL or more of blood within 12 weeks prior to participation 5) recent (past 4 months) participation in other clinical trial for investigational new chemical entity 6) history of drug abuse 7) alcohol abuse 8) taking drugs or healthy foods which may affect drug metabolism.
研究者
相似试验
已完成
不适用
Evaluation of relationship between pharmacokinetics and clinical response of voriconazole.JPRN-UMIN000011499Department of Hospital Pharmacy, Hamamatsu University School of Medicine200
招募中
不适用
Evaluation of relationship between pharmacokinetics and clinical response of voriconazole.JPRN-UMIN000023974Department of Hospital Pharmacy, Hamamatsu University School of Medicine100
进行中（未招募）
不适用
Relationships between pharmacokinetic and pharmacodynamic strategies for assessment of the risks for acute rejection and side effects of mofetil mycophenolate - NDKidney transplantationMedDRA version: 6.1Level: PTClassification code 10023439EUCTR2005-006162-33-ITROCHE45
已完成
不适用
DRUG INTERACTION POTENTIAL BETWEEN trans-RESVERATROL AND SIMVASTATICTRI/2023/02/049518SRM COLLEGE OF PHARMACY , SRM INSTITUTE OF SCIENCE AND TECHNOLOGY20
已完成
不适用
Study on the potential pharmacokinetic interaction between cannabidiol (CBD) and tamoxifen in patients with primary breast cancerNL-OMON52942Erasmus MC, Universitair Medisch Centrum Rotterdam26